{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:40:45Z","timestamp":1789656045183,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700514"],"award-info":[{"award-number":["81700514"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900515"],"award-info":[{"award-number":["81900515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbadis.2025.167815","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T13:31:55Z","timestamp":1743082315000},"page":"167815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rbm39 ameliorates metabolic dysfunction-associated steatotic liver disease by regulating Apob and Fabp4"],"prefix":"10.1016","volume":"1871","author":[{"given":"Chunbo","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167815_bb0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2025.167815_bb0010","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167815_bb0015","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41587-023-01680-4","article-title":"Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis","volume":"41","author":"Hendriks","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbadis.2025.167815_bb0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jacl.2022.07.008","article-title":"Novel APOB nonsense variant related to familial hypobetalipoproteinemia and hepatic steatosis: a case report and review","volume":"16","author":"Rodriguez de Vera-Gomez","year":"2022","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bbadis.2025.167815_bb0025","first-page":"e2200742","article-title":"Hepatic MDM2 causes metabolic associated fatty liver disease by blocking triglyceride-VLDL secretion via ApoB degradation","volume":"9","author":"Lin","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.bbadis.2025.167815_bb0030","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.32709","article-title":"Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion","volume":"78","author":"van Zwol","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2025.167815_bb0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/ATVBAHA.110.217828","article-title":"Hepatic hepatocyte nuclear factor 4alpha is essential for maintaining triglyceride and cholesterol homeostasis","volume":"31","author":"Yin","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2025.167815_bb0040","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/s41467-020-16918-x","article-title":"Hepatic HuR modulates lipid homeostasis in response to high-fat diet","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2025.167815_bb0045","doi-asserted-by":"crossref","first-page":"E1051","DOI":"10.1152\/ajpendo.00399.2011","article-title":"Translational control mechanisms in metabolic regulation: critical role of RNA binding proteins, microRNAs, and cytoplasmic RNA granules","volume":"301","author":"Adeli","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2025.167815_bb0050","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00109-017-1534-4","article-title":"CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia","volume":"95","author":"Song","year":"2017","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbadis.2025.167815_bb0055","doi-asserted-by":"crossref","first-page":"E1264","DOI":"10.1152\/ajpendo.00438.2013","article-title":"Hepatic mitochondrial and ER stress induced by defective PPARalpha signaling in the pathogenesis of hepatic steatosis","volume":"306","author":"Su","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2025.167815_bb0060","first-page":"124","article-title":"Fatty acid binding proteins: tissue-specific functions in health and disease","volume":"17","author":"Thumser","year":"2014","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bbadis.2025.167815_bb0065","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrendo.2015.122","article-title":"Metabolic functions of FABPs\u2014mechanisms and therapeutic implications","volume":"11","author":"Hotamisligil","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167815_bb0070","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2025.167815_bb0075","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/hep.22896","article-title":"Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"49","author":"Milner","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2025.167815_bb0080","doi-asserted-by":"crossref","first-page":"19785","DOI":"10.1038\/s41598-019-56235-y","article-title":"FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis","volume":"9","author":"Coilly","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.167815_bb0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2016.04.012","article-title":"Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells","volume":"249","author":"Bosquet","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2025.167815_bb0090","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhep.2012.10.022","article-title":"Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice","volume":"58","author":"Hoo","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167815_bb0095","doi-asserted-by":"crossref","first-page":"194902","DOI":"10.1016\/j.bbagrm.2022.194902","article-title":"Insights on the biological functions and diverse regulation of RNA-binding protein 39 and their implication in human diseases","volume":"1866","author":"Eleouet","year":"2023","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.bbadis.2025.167815_bb0100","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/bph.15331","article-title":"RNA-binding motif protein 39 (RBM39): an emerging cancer target","volume":"179","author":"Xu","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167815_bb0105","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.21037\/tcr-23-2252","article-title":"RBM39 is a potential prognostic biomarker with functional significance in hepatocellular carcinoma","volume":"13","author":"Cui","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167815_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3755","article-title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15","volume":"356","author":"Han","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167815_bb0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccell.2019.01.010","article-title":"Targeting an RNA-binding protein network in acute myeloid leukemia","volume":"35","author":"Wang","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2025.167815_bb0120","doi-asserted-by":"crossref","first-page":"119607","DOI":"10.1016\/j.bbamcr.2023.119607","article-title":"Regulatory role of RBM39 in acute myeloid leukemia: mediation through the PI3K\/AKT pathway","volume":"1871","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.bbadis.2025.167815_bb0125","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.cell.2021.05.038","article-title":"Pharmacologic modulation of RNA splicing enhances anti-tumor immunity","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167815_bb0130","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","article-title":"Arginine reprograms metabolism in liver cancer via RBM39","volume":"186","author":"Mossmann","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167815_bb0135","doi-asserted-by":"crossref","first-page":"e35985","DOI":"10.1097\/MD.0000000000035985","article-title":"Multiple-microarray analysis for identification of key genes involved in diabetic nephropathy","volume":"102","author":"Bi","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbadis.2025.167815_bb0140","doi-asserted-by":"crossref","first-page":"651142","DOI":"10.3389\/fcell.2021.651142","article-title":"Co-expression network revealed roles of RNA m6A methylation in human beta-cell of type 2 diabetes mellitus","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2025.167815_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5582\/bst.2022.01473","article-title":"RNA-binding proteins in metabolic-associated fatty liver disease (MASLD): from mechanism to therapy","volume":"17","author":"Xu","year":"2023","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.bbadis.2025.167815_bb0150","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrg3813","article-title":"A census of human RNA-binding proteins","volume":"15","author":"Gerstberger","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbadis.2025.167815_bb0155","doi-asserted-by":"crossref","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","article-title":"rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data","volume":"111","author":"Shen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbadis.2025.167815_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030214","article-title":"Hypoxia-inducible factors and the regulation of lipid metabolism","volume":"8","author":"Mylonis","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.167815_bb0165","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2015.05.030","article-title":"Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia\/reperfusion injury","volume":"63","author":"Hu","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167815_bb0170","doi-asserted-by":"crossref","first-page":"e1005116","DOI":"10.1371\/journal.pgen.1005116","article-title":"CAPER is vital for energy and redox homeostasis by integrating glucose-induced mitochondrial functions via ERR-alpha-Gabpa and stress-induced adaptive responses via NF-kappaB-cMYC","volume":"11","author":"Kang","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2025.167815_bb0175","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: recent developments","volume":"185","author":"Bjorkegren","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167815_bb0180","doi-asserted-by":"crossref","first-page":"154307","DOI":"10.1016\/j.metabol.2020.154307","article-title":"Defects in High Density Lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of Hepatocyte Nuclear Factor 4A","volume":"110","author":"Thymiakou","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2025.167815_bb0185","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/ncomms8466","article-title":"A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2025.167815_bb0190","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/MCB.21.4.1393-1403.2001","article-title":"Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis","volume":"21","author":"Hayhurst","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2025.167815_bb0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/BJ20080355","article-title":"Modulation of hepatocyte nuclear factor-4alpha function by the peroxisome-proliferator-activated receptor-gamma co-activator-1alpha in the acute-phase response","volume":"415","author":"Wang","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2025.167815_bb0200","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2025.167815_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010197","article-title":"Unveiling the role of the fatty acid binding protein 4 in the metabolic-associated fatty liver disease","volume":"10","author":"Moreno-Vedia","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbadis.2025.167815_bb0210","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1053\/j.gastro.2017.01.001","article-title":"Activation of the hypoxia inducible factor 1alpha subunit pathway in steatotic liver contributes to formation of cholesterol gallstones","volume":"152","author":"Asai","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2025.167815_bb0215","doi-asserted-by":"crossref","first-page":"118550","DOI":"10.1016\/j.bbamcr.2019.118550","article-title":"SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1alpha in lung cancer cells through alternative splicing mechanism","volume":"1866","author":"Chang","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.bbadis.2025.167815_bb0220","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02805","article-title":"Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex","volume":"3","author":"Kumar","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.bbadis.2025.167815_bb0225","doi-asserted-by":"crossref","first-page":"109156","DOI":"10.1016\/j.celrep.2021.109156","article-title":"Inhibiting an RBM39\/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferation","volume":"35","author":"Puvvula","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2025.167815_bb0230","doi-asserted-by":"crossref","first-page":"113307","DOI":"10.1016\/j.celrep.2023.113307","article-title":"Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma","volume":"42","author":"Xu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2025.167815_bb0235","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molcel.2004.12.025","article-title":"Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPERalpha and CAPERbeta","volume":"17","author":"Dowhan","year":"2005","journal-title":"Mol. Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:29:12Z","timestamp":1762324152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0925443925001607"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167815","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rbm39 ameliorates metabolic dysfunction-associated steatotic liver disease by regulating Apob and Fabp4","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167815"}}